Related Experiment Video
Updated: May 5, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
Efficiency of opportunistic population screening in a gastrointestinal endoscopy unit as a hepatitis C elimination
Antonio García-Herola1, María S Sánchez-Reyes2, Laura Gómez-Escolar1
1Digestive System Section.
Objective:
To assess the feasibility and acceptance of an opportunistic population-based screening program in a gastrointestinal endoscopy unit as a hepatitis C elimination strategy.
Methods:
A cross-sectional study was conducted in the Digestive Endoscopy Unit of a hospital in Spain between February 2019 and 2020.
Results:
The participation rate was 99.6%, and 4701 individuals were evaluated. The median age was 60 years, and 53.4% were women. A total of 70 participants were positive for hepatitis C virus (HCV) antibodies. The seroprevalence was 1.49% [95% confidence interval (CI): 1.14-1.84%]. Less than one-third of the HCV antibody-positive subjects were unaware of their condition. The overall active HCV infection prevalence was 0.26% (95% CI: 0.11-0.41%). The most frequent risk factors were previous surgical interventions and drug consumption. Approximately 80% of the anti-HCV-positive individuals were born between 1950 and 1980.
Conclusions:
Opportunistic screening of HCV-infected patients older than 40 years could contribute to the identification of HCV-infected patients and linkage to care for hepatitis C elimination at the hospital level. Gastrointestinal endoscopy units can be a good setting for opportunistic screening.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
03:23Fluorescent Laparoscopic Central Hepatectomy for Liver Cancer Using Indocyanine Green Negative Staining
Published on: March 17, 2023
Related Concept Videos
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test